A study aiming to find predictors of DC vaccine responses showed that glioblastoma patients with tumor-infiltrating lymphocytes (TILs) with a higher PD-1+/CD8+ ratio had worse prognosis (135). This evidence concerns the gene CD8A and neoplasm.